The gross proceeds to MapLight from the initial public offering and the concurrent private placement, before deducting underwriting discounts and commissions and offering expenses, were $296.3 million ...
Dewpoint Therapeutics, the leader in condensate biology, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to DPTX3186, its first-in-class ...
About Bioxytran, Inc. Bioxytran, Inc. is at the forefront of developing linear complex carbohydrate-based therapeutics to address critical unmet medical needs in its antiviral platform technology. For ...
About OXB OXB (LSE: OXB) is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life ...
NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Betterguards, a sports technology innovator, today announced the launch of The BetterGuard Lite, its most accessible and lightweight innovation to date.
Basel, October 29, 2025 – Novartis today presented new ianalumab data in Sjögren’s disease, the second most prevalent rheumatic autoimmune disease 2, at a late-breaker presentation during the American ...
Cannisco, formerly East Coast Collective, today announced its complete brand transformation, marking a new chapter for one of Virginia's most trusted vertically integrated hemp and cannabis wellness ...
Plum Tree Psychology is now accepting new participants for the Hoot & Holler Chronic Illness Therapy Program. Appointments can be scheduled online at theplumtree.net/chronic-illness-therapy or by ...
The presentation is available for download on the Anaptys website here.
Real world data show >70% of patients treated with VYVGART meaningfully reduced glucocorticoid use while maintaining clinical benefit Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), ...
Telitacicept demonstrated a favorable profile comparable to placebo and consistent with prior studies across other autoimmune indications, including systemic lupus erythematosus, rheumatoid arthritis, ...
MEDIROM Healthcare Technologies Inc., (Headquarters: Minato-ku, Tokyo; President and CEO: Kouji Eguchi; listed on the Nasdaq Stock Market under the ticker symbol NASDAQ: MRM; hereinafter “the Company” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback